Jean-Francois Grenier, M.D., D.A.

X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances.

C4Diagnostics is a French-based biotech specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases C4Diagnostics' strategy for the better management of Human infectious diseases, is to develop game changing IVD tests which are significantly faster than standard methods whilst maintaining comparable or better performance. Its portfolio currently focuses on the diagnosis of Covid-19 (C4Covid-19), Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). C4Diagnostics also has a business unit dedicated to environmental diagnostics, called C4Environment. It provides services for the detection of SARS-CoV-2 and other pathogens in the environment (wastewater, air, surface) and has contributed to several Covid-19 surveillance and prevention campaigns since the beginning of the pandemic. With its rapid and highly sensitive IVD tests, C4Diagnostics ambitions to become one of the main actors in the diagnosis of human infectious diseases field, by giving medical labs and healthcare professionals sensible and reliable diagnostic information in a timely manner. The game changing diagnostic solutions developed by C4Diagnostics are a leverage to fight against antibiotic resistance and curb infectious disease epidemics. contact@C4Diagnostics.com

Arts & Métiers Business Angels est un réseau national de Business Angels, initialement créé par des Alumni Arts & Métiers. Aujourdhui, lassociation regroupe 150 investisseurs (gadzarts ou non). Les membres du réseau investissent au capital de startups innovantes, à impact environnemental et sociétal fort. Nous apportons un soin particulier à laccompagnement des porteurs dès le démarrage de leur projet, et leur ouvrons notre réseau. Vous êtes porteur de projet dune startup innovante ? Dans un premier temps, déposez votre dossier sur la plateforme "Dealum"​ qui est notre interface privilégiée : https://s.42l.fr/AMBA Vous voulez investir dans des entreprises innovantes et rejoindre une association dynamique? Contactez-nous, nous répondrons à toutes vos questions.

X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances.

C4Diagnostics is a French-based biotech specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases C4Diagnostics' strategy for the better management of Human infectious diseases, is to develop game changing IVD tests which are significantly faster than standard methods whilst maintaining comparable or better performance. Its portfolio currently focuses on the diagnosis of Covid-19 (C4Covid-19), Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). C4Diagnostics also has a business unit dedicated to environmental diagnostics, called C4Environment. It provides services for the detection of SARS-CoV-2 and other pathogens in the environment (wastewater, air, surface) and has contributed to several Covid-19 surveillance and prevention campaigns since the beginning of the pandemic. With its rapid and highly sensitive IVD tests, C4Diagnostics ambitions to become one of the main actors in the diagnosis of human infectious diseases field, by giving medical labs and healthcare professionals sensible and reliable diagnostic information in a timely manner. The game changing diagnostic solutions developed by C4Diagnostics are a leverage to fight against antibiotic resistance and curb infectious disease epidemics. contact@C4Diagnostics.com

Arts & Métiers Business Angels est un réseau national de Business Angels, initialement créé par des Alumni Arts & Métiers. Aujourdhui, lassociation regroupe 150 investisseurs (gadzarts ou non). Les membres du réseau investissent au capital de startups innovantes, à impact environnemental et sociétal fort. Nous apportons un soin particulier à laccompagnement des porteurs dès le démarrage de leur projet, et leur ouvrons notre réseau. Vous êtes porteur de projet dune startup innovante ? Dans un premier temps, déposez votre dossier sur la plateforme "Dealum"​ qui est notre interface privilégiée : https://s.42l.fr/AMBA Vous voulez investir dans des entreprises innovantes et rejoindre une association dynamique? Contactez-nous, nous répondrons à toutes vos questions.

PharmExpand® provides personalized Executive Consulting to senior managers in the Biopharmaceutical industry in the fields of Strategy, Marketing and Market Access. PharmExpand advises also Funds Managers investing in Pharma and Biotech and young companies seeking financing. PharmExpand's founder and CEO, Dr. Jean-Francois Grenier is a seasoned executive with over 20 years of biopharmaceutical Leadership & Management experience acquired in North America, Asia and Europe. He will personally be involved in the mandate you give us. PharmExpand has established a network of highly qualified consultants with extensive real-life experience in the Life Sciences industries: The PharmExpand Alliance. These consultants have all occupied leading positions in various national, regional and global functions in Pharmaceutical, Biotech and Medical Device international companies. Specialized consultants in the PharmExpand Alliance have considerable expertise in Strategy, Marketing (strategic & operational), Sales, Drug Development, Regulatory as well as in Biotech Financing. The Alliance's footprint goes from North America, to Europe, Middle-East and Asia. PharmExpand: Global view and expertise to understand your business from Development to Market.